Aram Ko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Aram Ko has a total of 97 co-authors. Here are the top co-authors by number of shared publications:
- Anna Lasorella
Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, USA
33 shared publications - Antonio Iavarone
Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, USA
33 shared publications - Fulvio D'ANgelo
Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, USA
32 shared publications - Brulinda Frangaj
Columbia University Irving Medical Center
31 shared publications - Franck Bielle
Sorbonne Université, Paris Brain Institute-ICM, Inserm, CNRS, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, Department of Neuropathology, Paris, France
31 shared publications - Marc Sanson
Groupe Hospitalier Pitié-Salpêtrière
31 shared publications
Latest Publications
- Open Access
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from LZTR1 Mutation Mediates Oncogenesis through Stabilization of EGFR and AXL
The Kelch domain of LZTR1 and carboxyl tail of EGFR are required for their interaction
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S2 from LZTR1 Mutation Mediates Oncogenesis through Stabilization of EGFR and AXL
The Kelch domain of LZTR1 and carboxyl tail of EGFR are required for their interaction
- Open Access
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S6 from LZTR1 Mutation Mediates Oncogenesis through Stabilization of EGFR and AXL
EGFR and AXL protein expression in the brain and immunohistochemical characterization of tumors of Lztr1fl/fl;Cdkn2afl/fl;GFAP-Cre+ mice
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S6 from LZTR1 Mutation Mediates Oncogenesis through Stabilization of EGFR and AXL
EGFR and AXL protein expression in the brain and immunohistochemical characterization of tumors of Lztr1fl/fl;Cdkn2afl/fl;GFAP-Cre+ mice
- Open Access
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S8 from LZTR1 Mutation Mediates Oncogenesis through Stabilization of EGFR and AXL
Vulnerability of LZTR1 inactive cells to combination treatment of EGFR and AXL inhibitors
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S8 from LZTR1 Mutation Mediates Oncogenesis through Stabilization of EGFR and AXL
Vulnerability of LZTR1 inactive cells to combination treatment of EGFR and AXL inhibitors
- Open Access
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S1. from LZTR1 Mutation Mediates Oncogenesis through Stabilization of EGFR and AXL
LZTR1 regulates EGFR and AXL protein stability
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S1. from LZTR1 Mutation Mediates Oncogenesis through Stabilization of EGFR and AXL
LZTR1 regulates EGFR and AXL protein stability
- Open Access
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S4 from LZTR1 Mutation Mediates Oncogenesis through Stabilization of EGFR and AXL
LZTR1 co-localized with EGFR and AXL at the cellular membrane upon ligand stimulation
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S4 from LZTR1 Mutation Mediates Oncogenesis through Stabilization of EGFR and AXL
LZTR1 co-localized with EGFR and AXL at the cellular membrane upon ligand stimulation
- Open Access
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Tables S1-S3 from LZTR1 Mutation Mediates Oncogenesis through Stabilization of EGFR and AXL
Table S1. List of ubiquitylated peptides from DiGly proteomics assay. Table S2. List of proteins differentially abundant in LZTR1-/- compared toLZTR1+/+ cells quantified by TMT.Table S3. List of top scoring LZTR1 interacting proteins from immunoprecipitation/mass spectrometry.
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Tables S1-S3 from LZTR1 Mutation Mediates Oncogenesis through Stabilization of EGFR and AXL
Table S1. List of ubiquitylated peptides from DiGly proteomics assay. Table S2. List of proteins differentially abundant in LZTR1-/- compared toLZTR1+/+ cells quantified by TMT.Table S3. List of top scoring LZTR1 interacting proteins from immunoprecipitation/mass spectrometry.
- Open Access
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S3 from LZTR1 Mutation Mediates Oncogenesis through Stabilization of EGFR and AXL
Mechanism of LZTR1-mediated degradation of RIT1 and the effect of LZTR1 mutations
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S3 from LZTR1 Mutation Mediates Oncogenesis through Stabilization of EGFR and AXL
Mechanism of LZTR1-mediated degradation of RIT1 and the effect of LZTR1 mutations
- Open Access
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S7 from LZTR1 Mutation Mediates Oncogenesis through Stabilization of EGFR and AXL
Protein expression of LZTR1 substrates and pathway analysis in human schwannoma A
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S7 from LZTR1 Mutation Mediates Oncogenesis through Stabilization of EGFR and AXL
Protein expression of LZTR1 substrates and pathway analysis in human schwannoma A
- Open Access
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S5 from LZTR1 Mutation Mediates Oncogenesis through Stabilization of EGFR and AXL
Phenotype alterations in the liver and brain of Lztr1-deleted mice
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S5 from LZTR1 Mutation Mediates Oncogenesis through Stabilization of EGFR and AXL
Phenotype alterations in the liver and brain of Lztr1-deleted mice
- Open Access
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Tables S1-S3 from LZTR1 Mutation Mediates Oncogenesis through Stabilization of EGFR and AXL
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Tables S1-S3 from LZTR1 Mutation Mediates Oncogenesis through Stabilization of EGFR and AXL